Evidence map›Paper›PMID 34384660›Full record

ArticleJournal of voice : official journal of the Voice Foundation2023

Persistent Dysphonia in Hospitalized COVID-19 Patients.

Carlos Leis-Cofiño, Paula Arriero-Sánchez, Ramón González-Herranz, Óscar Arenas-Brítez, Estefanía Hernández-García, Guillermo Plaza

Open access · bronzeAbstract read
In one paragraph

Article in Journal of voice : official journal of the Voice Foundation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Carlos Leis-CofiñoHospital Universitario de Fuenlabrada, Universidad Rey Juan Carlos, Fuenlabrada, Madrid, Spain. Electronic address: carlosleis2402@gmail.com.
Paula Arriero-SánchezHospital Universitario de Fuenlabrada, Universidad Rey Juan Carlos, Fuenlabrada, Madrid, Spain.
Ramón González-HerranzHospital Universitario de Fuenlabrada, Department of Otorhinolaryngology, Fuenlabrada, Madrid, Spain.
Óscar Arenas-BrítezHospital Universitario de Fuenlabrada, Department of Otorhinolaryngology, Fuenlabrada, Madrid, Spain.
Estefanía Hernández-GarcíaHospital Universitario de Fuenlabrada, Department of Otorhinolaryngology, Fuenlabrada, Madrid, Spain.
Guillermo PlazaHospital Universitario de Fuenlabrada, Department of Otorhinolaryngology, Universidad Rey Juan Carlos, Fuenlabrada, Madrid, Spain.
Hospital Universitario de Fuenlabrada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe main objective of this study is to estimate the prevalence of persistent dysphonia in hospitalised COVID-19 patients.

methodsData were collected from those COVID-19 patients who, during the months of March to April 2020, were hospitalised in ward or intensive care unit at the University Hospital of Fuenlabrada. Patients with dysphonia prior to SARS-CoV-2 were excluded. Informed consent was obtained orally by a telephone call, as well as clinical and epidemiological data. Patients who reported persistent dysphonia were assessed using the Voice Handicap Index 10, the maximum phonation time, the s/z ratio and a fibrolaryngoscope examination. Patients who reported persistent dysphagia were assessed with the Eating Assessment Tool 10.

resultsA total of 79 patients were included in the study (48 men and 31 women). 10 ICU patients (25%) and 4 ward patients (10,3%) had dysphonia at least 3 months after hospital discharge, but no association was found between ICU admission and the presence of persistent dysphonia (P = 0.139). Persistent dysphonia in patients admitted to the ICU is associated with persistent dysphagia (P = 0.002), also the age of patients with persistent dysphonia is significantly higher than the age of non-dysphonic patients (P = 0.046). The most frequent exploratory finding was vocal cord paresis/paralysis (60.4%).

conclusionThis is one of the first studies to show that persistence of dysphonia may be a consequence of COVID-19, so further studies are needed to assess the evolution and prognosis of these patients and the possible association of dysphonia with the severity of the disease.

Indexed as

COVID-19Deglutition DisordersDysphoniaVocal Cord ParalysisFemaleHumansMaleSARS-CoV-2CoronavirusCOVID-19DysphagiaDysphoniaENTVoice

Identifiers

PMID34384660
PMCPMC8302831
OpenAlexW3186884787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.